to non-VBG in compromised tissue beds. Stronger spinal arthrodesis in turn, reduces reoperation risk and hardware dependence, and may allow for hardware removal. We have also illustrated the application of spare parts surgery using a vascularized femur-fibula. Overall, our experience supports using VBG in constructing spinal fusions, particularly in higher risk patients. 
Monday, October 9, 2017
Numerous surgical techniques exist for the treatment of first carpometacarpal joint osteoarthritis, however it unclear if outcomes differ between the available techniques. Our feasibility study aimed to determine the practicality of recruiting patients for, and performing, a larger-scale health-related quality of life and functional outcomes study comparing two surgical techniques: complete trapeziectomy with ligament reconstruction and tendon interposition (T+LRTI) and partial trapeziectomy and tendon interposition (PT) arthroplasty.
Sixty patients with advanced stage arthritis (Eaton stages II-IV) of the thumb, were invited to undergo either T+LRTI or PT at one of two hand surgery practices. Feasibility outcomes included: 1) Process: recruitment rate, 2) Resources: eligibility rate and sufficiency of eligibility criteria, retention and compliance rates (completion of HRQOL questionnaires, DASH, EQ-5D, and SF-36, and functional measurements, grip, key pinch, and tip pinch strength, at 1-week pre-operatively and 1, 3, 6, and 12 months post-operatively), 3) Management: determining the practices' commitment to the study, and 4) Scientific: calculation of the variance and effect size (ES) of differences between procedures.
Of 60 patients screened, 34 (57%) were eligible for surgery. Of the 26 ineligible patients, 21 (81%) met exclusion criteria for previous/imminent surgery on same hand, particularly carpal tunnel release (n=17). Of those who participated in the study, 14 (41%) attended at least one of the four follow-up visits, 24% and 89% from the T+LRTI and PT group, respectively. Attrition rate was 59%. The highest compliance rate was at 6 months. Large differences in loss to followup were seen between the two practices (16/25 vs 1/9); three different research assistants participated in the study. The estimate of treatment effect is large for some outcomes (SF-36 Mental Score =1.044, DASH disability score = 0.83, EQ-5D anxiety/depression = 1.106, and EQ-5D state of health = 0.84 and) and minimal to none for others (SF-36 Physical Score = 0.21, EQ-5D mobility, self-care, and pain/discomfort = 0, EQ-5D usual activities = 0.26).
The authors concluded that a large-scale study is feasible; however, the following changes are recommended: 1) increase sample size to account for attrition 2) remove exclusion of participants with carpal tunnel syndrome, 3) ensure rapport between office personnel and study patients, and 4) main stability with research assistants during the study period or ensure overlap in the transition period. 1 The mesh sheet supports the lower pole of the implant and reduces its weight on the skin envelope, reduces the post-surgical complication rate (particularly capsular contraction) and improves the aesthetic result. Seroma is the only complication shown to be more common when ADMs are used as compared to total muscle coverage without ADM. In light of the many advantages of using ADMs, there have been an increasing number options of biological mesh materials and designs used in breast reconstruction.
RESEARCH
Today, there is little comparative information between different ADMs and their incorporation process in human use or animal models. 2, 3, 4, 5 Moreover, the relationship between fenestration of ADM sheets, such as perforation with widely spaced slits or holes, or more densely spaced meshed expandable or non-expandable patterns, and the adherence and incorporation of ADMs to opposing soft tissues has not been well studied.
METHODS:
Alloderm, FlexHD, HuMend, Strattice and SurgiMend were implanted in a subcutaneous pocket on a pig's back. Each ADM type had at least two samples. Half of the samples were meshed 1:2.5. Tissues were collected at 3 months.
